Dr. Daniel Heller

Associate Member of Molecular Pharmacology
Affiliations

Memorial Sloan Kettering CC

Research Summary

We are inventing novel technologies to treat advanced cancers and to detect disease at early stages. We are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers of disease.

Website
Research Topics

Nanomedicine

Nanochemistry

Nanobiotechnology

Want to get in touch with Nanotech New York?

Be #Nanofabulous 

  • Twitter Social Icon
  • Instagram
  • m_swarm_630x630
  • Facebook Social Icon
  • LinkedIn Social Icon